Anthropic’s elaborate plan to keep Wall Street at bay

Anthropic cofounder and CEO Dario Amodei. | Bloomberg via Getty Images Anthropic wants to have it both ways. With its impending IPO, it wants to tap the vast riches of the public markets and insists it doesn't want to compromise its core mission of developing AI safely and for the benefit of humanity. But greater model capabilities bring greater risks, and shareholders eager for returns may have little patience for costly safety measures that slow products on their way to market.
Sam Altman, the CEO of Anthropic's archrival, OpenAI, has cited investor pressures as one reason the company is not pursuing an IPO this year. Anthropic hopes it can resist investor pressures with a mind-boggling governance structure.
… Read the full story at The Verge.
News is gathered automatically from public robotics & AI feeds on a schedule.
Related
"No human at the helm": Delaware plan would let AI agents run entire businesses
Owners of AI-run firms would evade liability for "reckless" AI, US Rep. Comer says.
Bank of America kindly asks that you don’t share your banking password with your AI assistant
The banking giant reminds customers that "you're responsible for activity" resulting from your AI agents' access.
Who’s really in charge at Anthropic after the IPO?
Here's a clear explanation of Anthropic's incredibly complex governance structure.
Anthropic IPO warns its AI could blackmail people, become sentient, end humanity
Seven potential AI nightmares pulled from Anthropic's 93-page "Risk Factor" tome.

Researchers are getting tired of OpenAI gatekeeping its breakthroughs
On Monday, OpenAI announced impressive breakthroughs in mathematics, computer science, and physics, along with what the company says is an evolving approach to communicating its findings. But despite its apparent course correction, researchers who spoke to The Verge are growing increasingly tired of
Anthropic Says It Will Revolutionize Biology—Some Day
In breathless press releases and posts, the company has touted its models’ ability to deliver scientific breakthroughs. But its IPO filing taps the brakes on just how fast its AI will lead to big discoveries.